Format

Send to

Choose Destination
Tuberculosis (Edinb). 2014 Mar;94(2):105-10. doi: 10.1016/j.tube.2013.11.003. Epub 2013 Dec 1.

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.

Author information

1
The Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK. Electronic address: Helen.mcshane@ndm.ox.ac.uk.
2
Public Health England, Porton Down, Porton, Salisbury, UK. Electronic address: ann.rawkins@phe.gov.uk.

Abstract

There is an urgent need for an improved TB vaccine. Vaccine development is hindered by the lack of immune correlates and uncertain predictive value of preclinical animal models. As data become available from human efficacy trials, there is an opportunity to evaluate the predictive value of the criteria used to select candidate vaccines. Here we review the efficacy in animal models of the MVA85A candidate vaccine in light of recent human efficacy data and propose refinements to the preclinical models with the aim of increasing their predictive value for human efficacy.

KEYWORDS:

Clinical; Efficacy; MVA85A; Pre-clinical; Vaccine

Comment in

PMID:
24369986
PMCID:
PMC3969587
DOI:
10.1016/j.tube.2013.11.003
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center